Article
Factors Associated With Greater Severity of Depression in Chilean Primary Care Patients
Prim Care Companion CNS Disord 2017;19(3):16m02051
Use and Value of the 7-Item Binge Eating Disorder Screener in Clinical Practice
Prim Care Companion CNS Disord 2017;19(3):16m02075
Psychological Assessment of Emirati Patients Pursuing Bariatric Surgery for Obesity
Prim Care Companion CNS Disord 2017;19(3):16m02090
Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States
Prim Care Companion CNS Disord 2017;19(3):16m02066
Untreated Dyslipidemia in Lebanese Patients With Schizophrenia
Prim Care Companion CNS Disord 2017;19(3):17m02099
Mental and Physical Health Conditions in US Combat Veterans: Results From the National Health and Resilience in Veterans Study
Prim Care Companion CNS Disord 2017;19(3):17m02118
Psychotherapy Casebook
Brief Report
Letter to the Editor
Depression and Osteoporosis: A Study of 100 Patients
Prim Care Companion CNS Disord 2017;19(3):16l02062
Brief Psychotic Episode Caused by Advair Diskus in a Pediatric Patient
Prim Care Companion CNS Disord 2017;19(3):16l02052
Treatment of Hypersexuality in an Elderly Patient With Frontotemporal Dementia in a Long-Term Care Setting
Prim Care Companion CNS Disord 2017;19(3):16l02031
Hypertensive Crisis Secondary to Factitious Disorder
Prim Care Companion CNS Disord 2017;19(3):16l02048
Autoerotic Asphyxiation: A Case Report
Prim Care Companion CNS Disord 2017;19(3):16l02057
A Peep Into "Peeping Tom": Successful Management of Cyclothymia Presenting as Voyeuristic Disorder
Prim Care Companion CNS Disord 2017;19(3):16l02070
A Case of Fluoxetine-Induced Lower Extremity Ecchymosis
Prim Care Companion CNS Disord 2017;19(3):16l02061
A Case of Caffeine Intolerance With Long-Term Use of Fluoxetine
Prim Care Companion CNS Disord 2017;19(3):16l02045
Clozapine-Induced Procalcitonin Elevation
Prim Care Companion CNS Disord 2017;19(3):16l02054
Use of Omega-3 Polyunsaturated Fatty Acids as Augmentation Therapy in Treatment-Resistant Schizophrenia
Prim Care Companion CNS Disord 2017;19(3):16l02040